請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34700完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 丁志音 | |
| dc.contributor.author | Man-Chun Chang | en |
| dc.contributor.author | 張嫚純 | zh_TW |
| dc.date.accessioned | 2021-06-13T06:23:27Z | - |
| dc.date.available | 2006-02-09 | |
| dc.date.copyright | 2006-02-09 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-01-24 | |
| dc.identifier.citation | Abdala N, Carney JM, Durante AJ, Klimov N, Ostrovski D et al. 2003. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. International Journal of STD & AIDS. 14(10):697-703,
Adusumalli J, Bonney EA, Odenat L, Jamieson DJ. 2004. Hepatitis C virus (HCV): prevalence in a gynecological urgent care clinic population. Infectious Diseases in Obstetrics & Gynecology. 12(1):9-12, Ahmed MA, Zafar T, Brahmbhatt H, Imam G, Ul HS et al. 2003. HIV/AIDS risk behaviors and correlates of injection drug use among drug users in Pakistan. Journal of Urban Health. 80(2):321-9, Backmund M, Meyer K, Henkel C, Reimer J, Wachtler M, Schutz CG. 2005. Risk Factors and predictors of human immunodeficiency virus infection among injection drug users. European Addiction Research. 11(3):138-44, Ball AL, Rana S, Dehne KL. 1998. HIV prevention among injecting drug users: responses in developing and transitional countries. [Review] [63 refs]. Public Health Reports. 113 Suppl 1:170-81, Barcellos C, Bastos FI. 1996. [Social networks and diffusion of AIDS in Brazil]. [Portuguese]. Boletin de la Oficina Sanitaria Panamericana. 121(1):11-24, Bergk A, Berg T, Neumann UP. 2005. Risk factors for the acquisition of hepatitis C. [Review] [66 refs]. Minerva Gastroenterologica e Dietologica. 51(1):7-14, Beyrer C, Razak MH, Lisam K, Chen J, Lui W, Yu XF. 2000. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS. 14(1):75-83, Bialek SR, Bower WA, Mottram K, Purchase D, Nakano T et al. 2005. Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users. Journal of Urban Health. 82(3):468-78, Blankenship KM, Bray SJ, Merson MH. 2000. Structural interventions in public health. [Review] [64 refs]. AIDS. 14 Suppl 1:S11-21, Bluthenthal RN, Kral AH, Lorvick J, Watters JK. 1997. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Medical Anthropology. 18(1):61-83, Bowker SL, Soskolne CL, Houston SC, Newman SC, Jhangri GS. 2004. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a Northern Alberta population. Canadian Journal of Public Health. Revue Canadienne de Sante Publique. 95(3):188-92,-Jun Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J et al. 2001. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ Canadian Medical Association Journal. 164(6):767-73, Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M et al. 2003. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 98(9):1257-65, Celentano DD, Munoz A, Cohn S, Vlahov D. 2001. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug & Alcohol Dependence. 61(3):315-22, Charles E.Dodgen, W.Michale Shea. 2000. Initation, Progression, and Maintenance of Psychoactive Substance Use Disorders. In Substance Use Disorder, 3:37-42. San Diego, California. Coppola RC, Manconi PE, Piro R, Di Martino ML, Masia G. 1994. HCV, HIV, HBV and HDV infections in intravenous drug addicts. European Journal of Epidemiology. 10(3):279-83, Deslandes SF, Mendonca EA, Caiaffa WT, Doneda D. 2002. [The concepts of risk and prevention from the perspective of injecting drug users]. [Portuguese]. Cadernos de Saude Publica. 18(1):141-51,-Feb Evans JL, Hahn JA, Page-Shafer K, Lum PJ, Stein ES et al. 2003. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health. 80(1):137-46, Farrell M, Gowing L, Marsden J, Ling W, Ali R. 2005. Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy. (16) suppl 1:67-75 Fischer B, Haydon E, Rehm J, Krajden M, Reimer J. 2004. Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada. Journal of Urban Health. 81(3):428-47, Friedman SR, Neaigus A, Jose B, Curtis R, Goldstein M et al. 1997. Sociometric risk networks and risk for HIV infection. American Journal of Public Health. 87(8):1289-96, Galea S, Vlahov D. 2002. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. [Review] [144 refs]. Public Health Reports. 117 Suppl 1:S135-45, Gerard C, Delwaide J, Vaira D, Bastens B, Servais B et al. 2005. Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium. Journal of Medical Virology. 76(4):503-10, Ghys PD, Saidel T, Vu HT, Savtchenko I, Erasilova I et al. 2003. Growing in silence: selected regions and countries with expanding HIV/AIDS epidemics. [Review] [23 refs]. AIDS. 17 Suppl 4:S45-50, Gish RG, Afdhal NH, Dieterich DT, Reddy KR. 2005. Management of hepatitis C virus in special populations: patient and treatment considerations. [Review] [67 refs]. Clinical Gastroenterology & Hepatology. 3(4):311-8, Gollub EL, Rey D, Obadia Y, Moatti JP. 1998. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sexually Transmitted Diseases. 25(9):483-8, Hammer GP, Kellogg TA, McFarland WC, Wong E, Louie B et al. 2003. Low incidence and prevalence of hepatitis C virus infection among sexually active non-intravenous drug-using adults, San Francisco, 1997-2000. Sexually Transmitted Diseases. 30(12):919-24, Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M. 2002. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 97(10):1277-87, Heimer R, Khoshnood K, Jariwala-Freeman B, Duncan B, Harima Y. 1996. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. Journal of Infectious Diseases. 173(4):997-1000, Johnson RA, Gerstein DR, Pach A, III, Cerbone FG, Brown J. 2002. HIV risk behaviors in African-American drug injector networks: implications of injection-partner mixing and partnership characteristics. Addiction. 97(8):1011-24, Kelen GD, Green GB, Purcell RH, Chan DW, Qaqish BF et al. 1992. Hepatitis B and hepatitis C in emergency department patients.[see comment]. New England Journal of Medicine. 326(21):1399-404, Knowlton A, Hua W, Latkin C. 2004. Social support among HIV positive injection drug users: implications to integrated intervention for HIV positives. AIDS & Behavior. 8(4):357-63, Knowlton AR, Hua W, Latkin C. 2005. Social support networks and medical service use among HIV-positive injection drug users: implications to intervention. AIDS Care. 17(4):479-92, Koester S, Glanz J, Baron A. 2005. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS & Behavior. 9(1):27-39, Kottiri BJ, Friedman SR, Neaigus A, Curtis R, Des J. 2002. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 30(1):95-104, Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. 1999. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 94(5):675-83, Latkin CA, Hua W, Tobin K. 2004. Social network correlates of self-reported non-fatal overdose. Drug & Alcohol Dependence. 73(1):61-7, Lyttleton C, Amarapibal A. 2002. Sister cities and easy passage: HIV, mobility and economies of desire in a Thai/Lao border zone. Social Science & Medicine. 54(4):505-18, Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K et al. 2004. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.[erratum appears in Am J Public Health. 2004 Nov;94(11):1847]. American Journal of Public Health. 94(7):1218-23, MacDonald DI, Newton M. 1981. The clinical syndrome of adolescent drug abuse. [Review] [42 refs]. Advances in Pediatrics. 28:1-25, Mandell W, Vlahov D, Latkin C, Oziemkowska M, Cohn S. 1994. Correlates of needle sharing among injection drug users. American Journal of Public Health. 84(6):920-3, Marlatt GA. 1996. Harm reduction: come as you are. [Review] [18 refs]. Addictive Behaviors. 21(6):779-88,-Dec Mohsen AH, Murad S, Easterbrook PJ. 2005. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London. HIV Medicine. 6(3):206-15, Nguyen TH, Hoang TL, Pham KC, van Ameijden EJ, Deville W, Wolffers I. 1999. HIV monitoring in Vietnam: system, methodology, and results of sentinel surveillance. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 21(4):338-46, NIDA. NIDA Home / Frequently Asked Questions:What is drug addiction? 2005. Ref Type: Internet Communication NIDA. Research Report Series - Heroin Abuse and Addiction. 2006. Ref Type: Internet Communication Norden L, Lidman C. 2005. Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs). Scandinavian Journal of Infectious Diseases. 37(6-7):493-6, O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS et al. 2005. Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 40(1):83-8, O'Donovan D, Cooke RP, Joce R, Eastbury A, Waite J, Stene-Johansen K. 2001. An outbreak of hepatitis A amongst injecting drug users. Epidemiology & Infection. 127(3):469-73, Perngmark P, Celentano DD, Kawichai S. 2003. Needle sharing among southern Thai drug injectors. Addiction. 98(8):1153-61, Pisani E, Dadun, Sucahya PK, Kamil O, Jazan S. 2003. Sexual behavior among injection drug users in 3 indonesian cities carries a high potential for HIV spread to noninjectors. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 34(4):403-6, Redick RT. 2002. The defense styles of outpatient substance abusers vs. non substance abusers. Dissertation Abstracts International: Section B: The Sciences and Engineering 63(4-B):2070 Reyes JC, Robles RR, Colon HM, Matos TD, Finlinson HA et al. 2005. Homelessness and HIV risk behaviors among drug injectors in Puerto Rico. Journal of Urban Health. 82(3):446-55, Rhodes T, Ball A, Stimson GV, Kobyshcha Y, Fitch C et al. 1999a. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction. 94(9):1323-36, Rhodes T, Judd A, Mikhailova L, Sarang A, Khutorskoy M et al. 2004. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: maximizing the protective effects of syringe distribution. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 35(3):293-300, Rhodes T, Simic M. 2005. Transition and the HIV risk environment.[see comment]. BMJ. 331(7510):220-3, Rhodes T, Stimson GV, Crofts N, Ball A, Dehne K, Khodakevich L. 1999b. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. [Review] [109 refs]. AIDS. 13 Suppl A:S259-69, Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S et al. 2004. A syringe prescription program to prevent infectious disease and improve health of injection drug users. Journal of Urban Health. 81(1):122-34, Ross MW, Wodak A, Stowe A, Gold J. 1994. Explanations for sharing injection equipment in injecting drug users and barriers to safer drug use. Addiction. 89(4):473-9, Ruan Y, Chen K, Hong K, He Y, Liu S et al. 2004. Community-based survey of HIV transmission modes among intravenous drug users in Sichuan, China. Sexually Transmitted Diseases. 31(10):623-7, Saelim A, Geater A, Chongsuvivatwong V, Rodkla A, Bechtel GA. 1998. Needle sharing and high-risk sexual behaviors among IV drug users in Southern Thailand. AIDS Patient Care & Stds. 12(9):707-13, Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM. 1998. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. European Journal of Epidemiology. 14(6):555-61, Sarkar K, Panda S, Das N, Sarkar S. 1997. Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India. Indian Journal of Public Health. 41(2):49-51,-Jun Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K et al. 1989. Risk factors for human immunodeficiency virus infection in intravenous drug users.[see comment]. New England Journal of Medicine. 321(13):874-9, Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H. 2004. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS. 35(5):503-10, Smyth BP, Barry J, Keenan E. 2001. Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction. 96(5):717-27, Soskolne V, Shtarkshall RA. 2002. Migration and HIV prevention programmes: linking structural factors, culture, and individual behaviour--an Israeli experience. Social Science & Medicine. 55(8):1297-1307, Strathdee SA, Galai N, Safaiean M, Celentano DD, Vlahov D et al. 2001. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine. 161(10):1281-8, Strathdee SA, van Ameijden EJ, Mesquita F, Wodak A, Rana S, Vlahov D. 1998. Can HIV epidemics among injection drug users be prevented?. [Review] [114 refs]. AIDS. 12 Suppl A:S71-9, Suh T, Mandell W, Latkin C, Kim J. 1997. Social network characteristics and injecting HIV-risk behaviors among street injection drug users. Drug & Alcohol Dependence. 47(2):137-43, Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E et al. 1995. Correlates of hepatitis C virus infections among injection drug users. [Review] [31 refs]. Medicine. 74(4):212-20, Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT et al. 2002. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.[see comment]. American Journal of Epidemiology. 155(7):645-53, UNODC Campaign. Think: Taking drugs can lead to HIV/AIDS. 2005. 11-19-0050. Ref Type: Internet Communication Valente TW, Vlahov D. 2001. Selective risk taking among needle exchange participants: implications for supplemental interventions. American Journal of Public Health. 91(3):406-11, Wiebel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B et al. 1996. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 12(3):282-9, Wodak A, Sarkar S, Mesquita F. 2004. The globalization of drug injecting. Addiction. 99(7):799-801, Wood E, Spittal PM, Kerr T, Small W, Tyndall MW et al. 2003. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Canadian Journal of Public Health. Revue Canadienne de Sante Publique. 94(5):355-9,-Oct Yang X. 2005. Does where we live matter? Community characteristics and HIV and sexually transmitted disease prevalence in southwestern China. International Journal of STD & AIDS. 16(1):31-7, Zaller N, Nelson KE, Aladashvili M, Badridze N, del RC, Tsertsvadze T. 2004. Risk factors for hepatitis C virus infection among blood donors in Georgia.[erratum appears in Eur J Epidemiol. 2004;19(10):987]. European Journal of Epidemiology.(6):547-53 Zamani S, Kihara M, Gouya MM, Vazirian M, Ono-Kihara M et al. 2005. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS.(7):709-16 中文部分 台語詞典 (Taiwanese dictionary)。http://daiwanway.dynip.com/cgi/tdict.acgi。 李順良、洪宏元(2004)。華台英詞彙句式對照集。台北:五南 防愛滋飆升,衛署擬送毒蟲針頭-毒癮染愛滋,每月增上百人;法務部反對:不但明顯違法,若領針頭後搶奪殺人,政府算不算幫兇。聯合報,A9版,話題,2005.05.08。 林式穀(2004)。海洛因的健康影響,第四期文獻回顧研析計畫報告書。台北:國家衛生研究院。 林信男(1997)。藥物濫用與防治。台北市 : 橘井文化。 林棋芳(2003)。監獄受刑人副文化之研究。國立中正大學犯罪防治研究所碩士論文。 周長楫(2000)。閩南語詞典-傳統與現代語彙大結合。台南:真平企業。 法務部/法務統計/統計專題分析/專案報告/毒品新制五年來實施概況(2003年11月)。http://www.moj.gov.tw/tpms/a92-1.aspx。搜尋時間2005.06.21。 法務部/法務統計/統計專題分析/專案報告/近二年毒品案件增加原因分析報告(1997年12月)。http://www.moj.gov.tw/tpms/a86.aspx。搜尋時間2005.06.21。 法務部/法務統計/最新統計資料/毒品案件統計摘要/摘要分析(2005年11月)。http://www.moj.gov.tw/ct.asp?xItem=35128&CtNode=11604。搜尋時間2006.01.07。 毒品減害計畫,褒貶不一-立委指不可行;學者:可降低愛滋和吸毒盛行率。民生報,A12版,醫藥新聞,2005.05.10。 毒品施用者愛滋防治專題報告。衛生署疾病管制局(2005.03)。 陳宜民(2005)。台灣靜脈毒癮者HIV-1的分子流行病學研究。台灣愛滋病學會第二次會員大會暨HIV相關研究成果研討會。台北市。 程百君(1999),國內藥物濫用現況及防制策略,學校衛生,第35 期。 程冠豪(2004)。成年海洛因濫用者衝動性、用藥信念、用藥渴求與復發意向關係之研究。國立中正大學犯罪防治研究所碩士論文。 賀曉東、方明(1998)。中國禁毒大視角。北平:北京大學。 愛滋防治與毒癮減害,公民會議即起報名。民生報,A12版,醫藥新聞,2005.05.04。 衛生署疾病管制局/新聞稿/無毒Party迎中秋-遠離愛滋有一套(2005/09/16)。http://www.cdc.gov.tw/index1024.htm。搜尋時間2005.09.18。 衛生署疾病管制局/新聞與活動/澳洲減害創始專家現身說法:台灣已面臨全面推行減害計畫的關鍵時刻(2005/12/16)。http://www.cdc.gov.tw/index_news_info.asp?data_id=202。搜尋時間2005.12.18。 衛生署/本屬新聞/防治毒癮愛滋,衛生署邀請國際毒癮減害計畫專家來台經驗分享(2005/08/12)。http://www.doh.gov.tw/cht/content.aspx?doc_no=41892。搜尋時間2005.08.30。 衛生署疾病管制局/愛滋資訊/愛滋病簡介/行政院衛生署疾病管制局編印-愛滋病問答手冊。http://www.cdc.gov.tw/index1024.htm。搜尋時間2005.11.13。 蔡墩銘(1988)。犯罪心理學。台北:正中書局。 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34700 | - |
| dc.description.abstract | 過去,注射藥癮者(IDUs)在HIV的防疫上,一直是讓人安心的一群,然而民國91年通報13例,民國92年的突增了74例,93年迅速成長到565例,而94年1至11月的短短11個月間,就已經通報了2055例,成長速度驚人,然而到目前尚無研究報告來探尋這中間的原因。
本研究正式資料的蒐集,是自94年2月開始至94年12月,於研究者所服務的矯正機關內,以深度訪談法以及焦點團體法的方式進行。研究的結果分為四部分呈現:首先以藥癮者的觀點出發,詮釋其生活的樣貌,描繪出藥的吸引力、藥友間的網絡關係以及藥癮者這些年經歷的興衰變化。接著為用藥行為的勾勒,包括吸食與注射的差異以及注射的情境脈絡。再來則是描述大環境所發生的事件對藥癮者所造成的影響,諸如毒品政策的改變、減害政策的實施、新興災難的衝擊、人口及成癮藥物的跨國流動、MSM族群的交會等。最後以共用稀釋液、共用針具、HIV知識缺乏或錯誤、性行為等因子點出藥癮者感染HIV的危險的情境。 藥癮文化的特色、藥友間盤根錯節的網絡關係,成為HIV防疫上的一大障礙,以「群」為單位的感染,正是HIV感染通報人數戲劇性上升的原因。在共用針具的行為上,藥癮者人對於執法人員的惶恐與不信任,可能也將影響減害計畫的成效。知識的不足,無論是完全不知道如何預防HIV感染、不知道共用針具會傳染、不知道共用稀釋液會傳染等,更是藥癮者感染HIV的重要因素,其中,更以不知道共用稀釋液的原因為最,但這又是藥癮者最常出現的行為。 透過這個研究,研究者做出兩點建議:一是加強知識的宣導,宣導內容除了注射行為中的危險因子之外,更應汲取外國的經驗,將其他傳染病(如肝炎)的危害加入宣導,宣導的最佳方式為充分運用藥癮者既已建構的緊密社會網絡,以矯正機關內的收容人為種子,漸漸將訊息散播。第二,則是排除藥癮者參與減害政策的障礙,讓政策更能達成目標。 | zh_TW |
| dc.description.abstract | In the past two decades, because of a consistently exceptionally low HIV seropositive rate, the injection drug users (IDUs) constitutes the least noticed “high risk” group in Taiwan’s HIV/AIDS prevention and control. The stable low prevalence has been changed since the beginning of the 21st century particularly while 565 HIV seropositves were reported in 2004 and the number abruptly increased to 2055 in 2005. The purpose of this study is thus to explore factors that might contribute to the outbreak of HIV infection among IDU population in Taiwan, and provide suggestions for current and future HIV/AIDS prevention and control policy and programs targeted on the IDUs group.
This research was conducted from February to December 2005. Qualitative data were collected through both in-depth interviewing and focus group interview in a correctional organization located in the northwest part of Taiwan. The major findings of the study include four parts. First, from IDUs’ point of view, their style of living was delineated, the attraction of the substance was emphasized, the networking and relationships among peer IDUs was outlined, and the rise and fall of their life course was depicted. Second, the pattern of drug use was articulated. Particularly highlighted were the difference between inhaling and injecting, and the context in which the injection of the addictive substance was carried on. Third, the impact of macro-level forces on the IDUs and their drug use pattern. The most significant points were the change of drug control policy, the implementation of harm reduction programs, the attack of disaster such as SARS, the transnational drift of population and drugs, and the contact with another high risk group such as MSM (men who have sex with men). Finally, situations which pose IDUs under the threat of HIV infection were indicated, including solvent sharing, syringe and needle sharing, deficiency and misconceptions in HIV/AIDS knowledge, and unsafe sex behaviors. The characteristic subculture of drug using and the intricate networks of IDU members constitute the most challenging barriers to HIV/AIDS control. In summary, the HIV infection in the past few years among the IDUs has dramatically turned out to be an outbreak is due mainly to collective transmission, i.e., the spread of HIV was achieved through contagion between “groups,” not individuals. Two suggestions are proposed on the findings of the study. First, we should enhance the IDUs’ knowledge and skills in HIV/AIDS prevention, and the most efficient strategy is to utilize their unique networking interaction, starting from the IDU members in the correctional organizations, to develop a special type of peer training and education. Moreover, issues related to other infectious diseases such as hepatitis B and C should also be incorporated into the educational efforts. Secondly, barriers for IDUs to participate in harm reduction programs should be identified and eliminated. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T06:23:27Z (GMT). No. of bitstreams: 1 ntu-95-R92845106-1.pdf: 1613527 bytes, checksum: a9d2ea075a15db9d40bdc624649e773c (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | 第一章 緒論 1
第一節 我為何在這裡 1 第二節 關於這篇故事 2 第二章 文獻探討 5 第一節 成癮藥物 5 第二節 成癮藥物注射與愛滋及其他傳染病 8 第三節 注射藥癮者感染愛滋病毒的危險因子 9 第四節 減害政策 13 第三章 研究方法 15 第一節 前驅研究 15 第二節 研究場域的選擇 16 第三節 研究對象與選樣策略 17 第四節 資料蒐集 19 第五節 資料分析 29 第六節 資料鋪陳與詮釋 30 第七節 研究倫理 32 第四章 藥國 34 第一節 藥國印象 34 第二節 藥國生活與藥國朋友 40 第三節 藥國興衰與變化 46 第五章 用藥 52 第一節 吸食與注射 52 第二節 打藥就是這麼回事 57 第六章 藥國外發生什麼事 60 第一節 毒品政策的急轉彎 60 第二節 藥國與MSM的相逢 63 第三節 雪上加霜之新興災難 65 第四節 人口及成癮藥物的跨國流動 67 第五節 減害?真害! 69 第七章 探尋危險因子 76 第一節 共用水 76 第二節 共用針具 82 第三節 HIV/AIDS知識的缺乏或錯誤傳遞 93 第四節 性行為 97 第八章 討論 102 第一節 藥國的樣貌與群體文化 102 第二節 感染HIV的危險情境 107 第三節 對清潔針具計畫的回應 111 第四節 研究特點與限制 112 第九章 結論與建議 114 參考文獻…………………………………………118 附件………………………………………………129 圖表目錄 表3-1 選樣方法表……………………………………19 表3-2 感染HIV受訪者基本資料概況…………………23 表3-3 未感染HIV受訪者基本資料概況………………24 表3-4 焦點團體受訪者基本資料概況…………………26 圖3-1 深度訪談示意圖…………………………………22 圖3-2 焦點團體A座位圖………………………………28 圖3-3 焦點團體B、焦點團體C座位圖…………………28 圖5-1 藥物的循環使用…………………………………59 圖6-1 藥國內外變化圖…………………………………75 圖8-1 藥物的循環使用…………………………………103 圖8-2 藥物的集體使用…………………………………104 圖8-3 藥國樣貌示意圖…………………………………105 圖8-4 藥國「群」染示意圖……………………………106 圖8-5 集體使用感染危機圖……………………………110 | |
| dc.language.iso | zh-TW | |
| dc.subject | HIV感染 | zh_TW |
| dc.subject | 次文化 | zh_TW |
| dc.subject | 減害計畫 | zh_TW |
| dc.subject | 藥物濫用 | zh_TW |
| dc.subject | 注射藥癮者 | zh_TW |
| dc.subject | HIV infection | en |
| dc.subject | IDUs | en |
| dc.subject | subculture | en |
| dc.subject | substance abuse | en |
| dc.subject | harm reduction | en |
| dc.title | 成癮藥物使用情境脈絡與HIV感染關聯之初探 | zh_TW |
| dc.title | Exploring the Context of Drug Use and HIV Infection | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 陳宜民,謝菊英 | |
| dc.subject.keyword | 注射藥癮者,HIV感染,次文化,減害計畫,藥物濫用, | zh_TW |
| dc.subject.keyword | IDUs,HIV infection,subculture,harm reduction,substance abuse, | en |
| dc.relation.page | 130 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2006-01-24 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 衛生政策與管理研究所 | zh_TW |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-95-1.pdf 未授權公開取用 | 1.58 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
